glp 1 drugs for sleep apnea Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Obstructive Syndrome Management: A Narrative Review Sleep Apnea, GLP-1 Medications &
Description
Lixisenatide: A New Option for Managing Type 2 Diabetes
Arrone, who has led numerous clinical studies on GLP-1 medications and other obesity treatments, also emphasized the need for resistance training to protect muscle mass during weight loss because muscle loss happens more often when people eat very little and lose weight fast
It contributes to a variety of disorders, including type 2 diabetes, cardiovascular disease, hypertension, stroke, and cancer
About four in ten adults ages 50 to 64 and 65 and older say they have heard a lot about GLP-1 drugs, compared to about one-third of adults ages 30-49 (32%) and one in six adults ages 18-29 (17%)
Lee JM, Sharifi M, Oshman L, Griauzde DH, Chua KP
